Posted inLondon Stock Exchange
Aktis Oncology announces $318 million IPO
LONDON: RTW Biotech Opportunities Ltd, the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, notes the announcement by one…